Shares shifted sharply higher after Teradyne posted a quarter that silenced pre-earnings skeptics. The company reported Q2 2026 results on July 28, beating estimates with non-GAAP earnings of $2.47 per share versus the $2.11 Wall Street expected — a 20% upside surprise.

Revenue surged 104% year over year to $1.33 billion , marking a second consecutive record quarter. The stock, which had fallen roughly 23% from its June peak amid a chip-sector rout, is recouping much of that loss in a single session.

• The AI Testing Boom Is Real — and Accelerating

Semiconductor Test generated $1.12 billion of the quarter's revenue, with record memory-chip testing driven by strength in DRAM and a comeback in NAND flash testing.

About 70% of Teradyne's revenue is now tied to AI-related demand , meaning the company's fortunes rise or fall with data-center buildouts and advanced chip production. That concentration is a double-edged sword: spectacular when orders flow, dangerous if AI spending pauses.

• Next Quarter's Guidance Surprised Even the Bulls

Q3 revenue guidance of roughly $1.25 billion at the midpoint came in 21% above what analysts had penciled in , directly addressing the fear that had hammered the stock — that the boom might be fading. CEO Greg Smith said "robust AI-related demand" underpins the near-term outlook, adding that rising wafer-fab equipment investment "sets the stage for continued growth in 2027 and beyond."

• The Valuation Debate Gets Louder

Before this report, Teradyne traded at roughly 40 times its next-twelve-months earnings before interest, taxes, and depreciation — rare territory for test equipment.

Analyst targets range widely, from a cautious $370 (Evercore) to an aggressive $550 (Cantor Fitzgerald), with a median around $443. The blowout quarter validates the bulls, but the stock's cyclicality means investors are essentially betting this AI-driven demand persists across 2027 — a bet, not a certainty.

• Insiders Have Been Selling Into the Rally

Over the past six months, Teradyne insiders made 17 open-market trades — all sales, including CEO Greg Smith, who sold roughly 16,600 shares worth about $6 million. Insider selling during a surge isn't unusual, but the zero purchases stand out when management is publicly talking up a multi-year growth runway.

Bottom line: Teradyne delivered perhaps the cleanest earnings beat in the chip sector this season. The question now is whether a company historically tied to cyclical chip orders deserves a valuation usually reserved for software firms. Until AI demand proves durable beyond 2026, the premium carries real risk.